Corbus Pharmaceuticals Holdings (CRBP) Price to Book (2014 - 2025)

Corbus Pharmaceuticals Holdings has reported Price to Book for 12 years, with the latest figure at 0.69 in Q4 2025.

• On a quarterly basis, Price to Book fell 31.45% year-over-year to 0.69 in Q4 2025; TTM through Dec 2025 was 0.69, a 31.45% decrease from a year earlier, with the FY2025 full-year figure at 0.67, down 33.39% from the prior year.
• Price to Book was 0.69 for Q4 2025 at Corbus Pharmaceuticals Holdings, down from 1.72 in the prior quarter.
• The five-year high for Price to Book was 95.56 in Q3 2023, with the low at 3.87 in Q4 2023.
• Average Price to Book over 5 years is 21.54, with a median of 3.5 recorded in 2023.
• The largest YoY upside for Price to Book was 546.38% in 2023 against a maximum downside of 1023.18% in 2023.
• Over 5 years, Price to Book stood at 33.47 in 2021, then sank by 98.75% to 0.42 in 2022, then plunged by 1023.18% to 3.87 in 2023, then jumped by 126.08% to 1.01 in 2024, then tumbled by 31.45% to 0.69 in 2025.
• The last three Price to Book figures came in at 0.69 (Q4 2025), 1.72 (Q3 2025), and 0.76 (Q2 2025), per Business Quant data.